(NP (NP-COOD (NP (NP (JJ Uneven) (NN X) (NN inactivation)) (PP (IN in) (NP (NP (DT a) (JJ female) (JJ monozygotic) (JJ twin) (NN pair)) (PP (IN with) (NP (NN Fabry) (NN disease)))))) (CC and) (NP (NP (JJ discordant) (NN expression)) (PP (IN of) (NP (DT a) (JJ novel) (NN mutation))) (PP (IN in) (NP (DT the) (NN alpha-galactosidase) (NN A) (NN gene))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP describe) (NP (NP (CD two) (JJ female) (ADJP (ADJP (JJ monozygotic)) (PRN (-LRB- -LRB-) (ADJP (JJ MZ)) (-RRB- -RRB-))) (NNS twins)) (ADJP (JJ heterozygous) (PP (IN for) (NP (NP (NN Fabry) (NN disease)) (, ,) (NP (NP (DT an) (ADJP (NN X) (VBN linked)) (NN disorder)) (VP (VBG resulting) (PP (IN from) (NP (NP (DT the) (JJ deficient) (NN activity)) (PP (IN of) (NP (NN alpha-galactosidase) (NN A)))))))))))) (. .))
(S (SBAR (IN While) (S (NP-SBJ (NP (CD one)) (PP (IN of) (NP (DT the) (NNS twins)))) (VP (VBD was) (ADVP (RB clinically)) (ADJP-PRD (VBN affected))))) (, ,) (NP-SBJ (DT the) (JJ other)) (VP (VBD was) (ADJP-PRD (JJ asymptomatic))) (. .))
(S (NP-SBJ (NP (JJ Enzymatic) (NN assay)) (PP (IN of) (NP (NP (NN alpha-galactosidase)) (PP (IN in) (NP (NP-COOD (NP (NN blood) (NNS leucocytes)) (, ,) (NP (NN skin) (NNS fibroblasts)) (, ,) (NP (ADJP (NP (JJ Epstein-Barr) (NN virus)) (VBD transformed)) (JJ lymphoid) (NN cell) (NNS lines)) (, ,) (CC and) (NP (NN hair) (NNS follicles))) (PP (IN of) (NP (NP (DT the) (NNS twins)) (CC and) (NP (PRP$ their) (NNS parents))))))))) (VP-COOD (VP (VBD confirmed) (NP (NP (DT the) (JJ heterozygous) (NN status)) (PP (IN of) (NP (DT the) (NNS twins))))) (CC and) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ (NN Fabry) (NN disease)) (VP (VBD had) (VP (VBN occurred) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (DT a) (ADJP (FW de) (FW novo)) (NN mutation))))))))))) (. .))
(S (NP-SBJ-40 (NP (DT The) (NN son)) (PP (IN of) (NP (DT the) (JJ unaffected) (NN twin) (NN sister)))) (VP (VBD was) (VP (VBN shown) (S (NP-SBJ (-NONE- *-40)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ hemizygous))))))) (. .))
(S (NP-SBJ (NP (JJ Molecular) (NN analysis)) (PP (IN of) (NP (DT the) (NN alpha-galactosidase) (NN A) (NN gene)))) (VP (VBD permitted) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT an) (ADJP (ADVP (RB as) (RB yet)) (JJ undescribed)) (NN point) (NN mutation)) (PP (IN at) (NP (NP (NN position) (CD 10182)) (PP (IN of) (NP (NN exon) (CD 5))))) (SBAR (WHNP-41 (WDT which)) (S (NP-SBJ (-NONE- *T*-41)) (VP (VBZ causes) (NP (NP (DT an) (NP-COOD (NP (NN Asp)) (TO to) (NP (NN Asn))) (NN substitution)) (PP (IN at) (NP (NN codon) (CD 231))))))))))) (. .))
(S (NP-SBJ (NP (JJ Single) (NN strand) (NN conformation) (NN polymorphism)) (PRN (-LRB- -LRB-) (NP (NN SSCP)) (-RRB- -RRB-)) (NN analysis)) (ADVP-TMP (RB again)) (VP (VBD showed) (NP-COOD (NP (NP (DT the) (JJ heterozygous) (NN status)) (PP (IN of) (NP (DT the) (NNS twins)))) (CC and) (NP (NP (DT a) (JJ normal) (NN pattern)) (PP (IN in) (NP (PRP$ their) (NNS parents)))))) (. .))
(S (NP-SBJ-42 (NP (DT The) (NN basis)) (PP (IN for) (NP (NP (DT the) (JJ discordant) (NN expression)) (PP (IN of) (NP (NP (DT this) (ADJP (FW d) (FW novo)) (NN mutation)) (PP (IN in) (NP (DT the) (NNS twins)))))))) (VP (VBD was) (VP (VBN investigated) (NP (-NONE- *-42)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG studying) (NP (PRP$ their) (NN X) (NN inactivation) (NN status))))))) (. .))
(S (NP-SBJ (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (ADJP (NP (JJ inactive) (NN X)) (JJ specific)) (NN methylation)) (PP (IN at) (NP (DT the) (NN androgen) (NN receptor) (NN gene)))))) (VP (VBD showed) (NP (NP (JJ unbalanced) (NN inactivation)) (PP-COOD (PP (IN in) (NP (NP (DT the) (NNS twins) (POS ')) (NNS fibroblasts))) (CC and) (PP (IN in) (NP (JJ opposite) (NNS directions)))))) (. .))
(S (SBAR (IN While) (S (NP-SBJ (DT the) (ADJP (RB maternally) (VBN derived)) (NN X) (NN chromosome)) (VP (VBD was) (ADJP-PRD (RB preferentially) (JJ active)) (PP (IN in) (NP (DT the) (JJ asymptomatic) (NN twin)))))) (, ,) (NP-SBJ-43 (DT the) (JJ paternal) (NN X) (NN chromosome)) (VP-COOD (VP (VBD was) (ADJP-PRD (JJ active)) (PP (IN in) (NP (DT the) (ADJP-COOD (ADJP (JJ other)) (, ,) (ADJP (VBN affected))) (NN twin)))) (CC and) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-43)) (PP (IN in) (NP (PRP$ her) (JJ hemizygotic) (NN nephew)))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (DT the) (JJ paternal) (NN X) (NN chromosome)) (VP (VBZ carries) (NP (DT the) (ADJP (FW de) (FW novo)) (NN alpha-galactosidase) (NN A) (NN mutation))))) (CC and) (SBAR (IN that) (S (NP-SBJ (JJ uneven) (NN X) (NN inactivation)) (VP (VBZ is) (NP-PRD (NP (DT the) (VBG underlying) (NN mechanism)) (PP (IN for) (NP (NP (NN disease) (NN expression)) (PP (IN in) (NP (DT this) (JJ novel) (NN female) (JJ MZ) (NN twin) (NN pair))))))))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBZ is) (NP-PRD (NP (DT the) (JJ first) (VBN documented) (NN case)) (PP (IN of) (NP (NP (JJ female) (NNS twins)) (ADJP (JJ discordant) (PP (IN for) (NP (NN Fabry) (NN disease)))))))) (. .))
